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Background & aims: The quality of carbohydrates has an essential role in nutritional management of type
2 diabetes mellitus (T2DM) because of its substantial impact on glucose homeostasis. Alcohol-free beer
has beneficial bioactive components but it has a relatively high glycemic-index so its consumption is
restricted in diabetic subjects. We aimed to explore the effect of an alcohol-free beer with modified
carbohydrate composition almost completely eliminating maltose and adding isomaltulose (16.5 g/day)
and a resistant maltodextrin (5.28 g/day) in comparison to a regular alcohol-free beer on glycemic
control of diabetic subjects with overweight or obesity.
Design: We randomized 41 subjects into two groups: a) consumption of 66 cL/day of; regular alcohol-
free beer for the first 10 weeks and 66 cL/day of alcohol-free beer with modified carbohydrate
composition for the next 10 weeks; b) the same described intervention in opposite order. There was a
washout period for 6e8 weeks between the two interventions. Participants were counseled to adhere to
a healthy diet for cardiovascular health and to increase physical activity. Clinical, biochemical, anthro-
pometric, lifestyle and satiety assessments were performed at the beginning and at the end of each
period.
Results: Subjects showed significantly weight loss after the two ten weeks periods (1.69 ± 3.21%
and 1.77 ± 3.70% after experimental and regular alcohol-free beers, respectively, P ¼ 0.881). Glucose
and glycated hemoglobin did not significantly change after any period. Insulin concentrations and
HOMA-IR significantly decreased (11.1 [e21.34.64]% and 1.92 ± 32.8% respectively) after the intake
of experimental alcohol-free beer but not after regular alcohol-free beer. Reductions remained statisti-
cally significant after adjusting for weight loss, energy intake, physical activity and intervention order.
Subjects reported higher satiety scores after consuming experimental alcohol-free beer.
Conclusions: An alcohol-free beer including the substitution of regular carbohydrates for low doses of
isomaltulose and the addition of a resistant maltodextrin within meals led to an improvement in insulin
resistance in subjects with T2DM and overweight or obesity.
Clinical trial registration: The clinical trial has been registered in ClinicalTrials.gov (Identifier:
NCT03337828).
© 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.ody mass index; CRP, C-reactive protein; GGT, Gamma-glutamyl transferase; GI, Glycemic index; GLP-1, Glucagon-like
1c, Glycated hemoglobin; HOMA-IR, Homeostasis model assessment of insulin resistance; T2DM, Type 2 diabetes
gacion en Lípidos y Aterosclerosis, Hospital Universitario Miguel Servet, Paseo Isabel La Catolica, 1-3, 50009, Zaragoza,
quiz-Moneo).
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Diabetes mellitus burden is becoming a cause of concern due to
its rapidly increasing global prevalence, complications and the
excessive mortality rate which follows from its diagnosis [1,2].
Lifestyle intervention is a key issue in diabetes management and
includes, among other aspects, medical nutrition therapy [3]. In the
presence of overweight or obesity, weight loss constitutes one of
the key objectives of treatment. However, there is limited evidence
on the optimal diet to control hyperglycemia and obesity in type 2
diabetes mellitus (T2DM). The amount and type of carbohydrate is
one of the cornerstones in nutrition therapy of T2DM patients since
they commonly comprise fifty percent or more of all calories
consumed, and they have a substantial impact on glucose homeo-
stasis [4]. The effect of low-carbohydrate diets in patients with
T2DM remains unclear [3,5,6]. Beyond the quantity, carbohydrate
composition directly impacts postprandial glucose control [7]. The
metabolic effects of carbohydrate-containing foods are determined,
mainly, by their content of sugars, dietary fiber, glycemic responses
to digestion, processing and whole-grain content. Several clinical
trials have documented the beneficial effect of low-glycemic index
(GI) diets on glycemic control in T2DM [8]. More recently, several
studies have demonstrated that the impact of carbohydrates on
insulin secretion and postprandial glycemia can substantially
change depending on the types of foods with which the carbohy-
drates are consumed [9].
Isomaltulose, a disaccharide composed of a-1,6elinked glucose
and fructose, was recently introduced as an alternative sugar with
delayed digestion and absorption resulting in a low GI of 32 [10]. A
relatively high isomaltulose consumption (over 20 g per day) leads
to cardiometabolic benefits including glycemic control, macronu-
trient oxidation and improved lipid profile, both in healthy and in
diabetic patients [11]. Resistant dextrin is a glucose polymer (rich in
a-1,4 and a-1,6 linkages) derived from wheat or maize [12]. It is
incompletely hydrolyzed and absorbed in the small intestine, while
the majority is fermented in the colon. High doses (10 g) of
resistant dextrin induce beneficial effects on glycemic status, sys-
temic inflammation, body weight, and body composition in
humans [13e15]. To the best of our knowledge, no study has pre-
viously explored the potential synergistic beneficial effect of iso-
maltulose and resistant dextrin in glucose homeostasis of subjects
with prediabetes or T2DM.
Beer is over 90% water while the rest of components are mainly
carbohydrates (glucose polymers) and alcohol. As a product of
cereals fermentation of cereals, beer has B-complex vitamins, in
particular folate and choline, and trace amounts of minerals such
as potassium, calcium and magnesium [16]. Beer composition also
includes a range of polyphenols such as flavonoids and phenolic
acids that have protective effects on cardiovascular health as
measured by inflammatory biomarkers, among other biomarkers
[17e20]. Beer is widely consumed and it is often a preferred drink
both in social events and on a daily basis. However, beer is usually
restricted in T2DM patients because of its high content of carbo-
hydrates and alcohol [3,5]. Alcohol-free beer has the same
bioactive compounds (although in lower concentrations) than
regular beer, excluding the alcohol [16,21]. GI is estimated as 119
in regular beer and 80 in alcohol-free beer, which is similar to that
of potatoes, white bread or rice. In this context, we aimed to
explore the effects of an alcohol-free beer with modified carbo-
hydrates (almost completely eliminating maltose and adding
isomaltulose (16.5 g/day) and a resistant maltodextrin (5.28 g/
day)) on glycemic control (HOMA-IR as main outcome) in diabetic
subjects who are overweight or obese, in comparison to an
alcohol-free beer with regular composition to overcome thePlease cite this article as: Mateo-Gallego R et al., Effect of an alcohol-fre
resistance in diabetic patients with overweight or obesity, Clinical Nutritrestrictions to regular beer for T2DM. A secondary and explor-
atory objective of the study was to address the effect of modified
alcohol-free beer on satiety.
2. Material and methods
2.1. Study design and subjects
A randomized, controlled, double-blind designwith two parallel
groups was performed among volunteers of both sexes aged 18e80,
with a body mass index (BMI) ranging from 25 to 40 kg/m2 and
steady weight (±4 Kg) in the previous 2 months. We included those
subjects with any of the following criteria: a) Diagnosis of predia-
betes or T2DM according to international guidelines (fasting
glucose concentration 100 mg/dL and/or glycated hemoglobin
(HbA1c)  5.7%, and not taking antidiabetic drugs); b) Previous
diagnosis of prediabetes or T2DM on stable dose of metformin for 2
months, regardless of glucose and/or HbA1c levels. We excluded
those subjects with poorly controlled diabetes defined as HbA1c
concentration over 7%. Other exclusion criteria were: gluten intol-
erance, lipid-lowering drugs and/or supplements of sterols or
omega-3 fatty acids, weight loss medications, kidney disease
(glomerular filtration rate < 45 mL/min), active liver disease, un-
controlled hypothyroidism, and any other disease or condition that
could limit the study compliance.
2.2. Recruitment and pre-screening
Volunteers were recruited by public advertisements on local
television and newspapers. They were invited to an informative
session in which study objectives, and inclusion and exclusion
criteria were explained in depth. Participants willing to participate
completed a questionnaire that included: body weight, height,
medical history, common medications, and availability to parti-
cipate. Those volunteers who completed the study questionnaire
and were eligible according to the inclusion and exclusion criteria
were scheduled for a pre-screening visit. The visit was performed to
assess eligibility criteria. It included clinical and anthropometric
measurements to confirm that participants met BMI and other
clinical criteria like gluten tolerance or pharmacological use, among
others. We reviewed the most recently (<2 months) glucose and
HbA1c concentrations to check inclusion and exclusion criteria. If
not available, we performed a blood extraction collection to assess
these values according to the described methodology. If participant
was eligible to enter the study, theywere providedwith dietary and
exercise counseling and a randomization visit was scheduled 2e4
weeks later. We aimed to stabilize the lifestyle among participants
during the entire study. Informed consent was obtained at this visit
(Fig. 1).
The trial was carried out in the Clinical and Research Unit on
Lipids and Atherosclerosis (Hospital Universitario Miguel Servet at
Zaragoza (Spain)) from February 2017 to December 2017. The study
protocol was approved by the local institutional ethical committee
(Comite de Etica e Investigacion Clínica de Aragon). All procedures
were in accordance with the ethical standards of that committee.
This clinical trial was registered in ClinicalTrials.gov under identi-
fier NCT03337828.
2.3. Randomization and intervention
Participants were randomized into two groups (Fig. 1): a) con-
sumption of two bottles (33 cL each) per day of alcohol-free beerwith
regularcomposition for thefirst 10weeksand twobottles (33 cLeach)
per day of alcohol-free beer with modified carbohydratese beer enriched with isomaltulose and a resistant dextrin on insulin
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Fig. 1. Study design description.
R. Mateo-Gallego et al. / Clinical Nutrition xxx (xxxx) xxx 3composition for the next 10 weeks; b) the same described interven-
tion in opposite order. There was a washout phase for 6e8 weeks
between the two interventionphases, duringwhich timeno beerwas
consumed. Alcohol-free beerwithmodified carbohydrates included a
complete fermentationwhich almost completely eliminated maltose
(0.07 g/100 mL) and the addition of isomaltulose (2.5 g/100 mL) and
resistantmaltodextrin (0.8 g/100mL). Theparticipants received16.5g
per day of isomaltulose and 5.28 g per day of resistant dextrin. The
complete nutritional composition of both alcohol-free beers is pro-
vided in Supplemental Table 1.
Alcohol-free beers were provided to participants without charge
and they were counseled to take the beers within main meals
(lunch and dinner). Volunteers and research staff were blinded to
the type of beer that individuals were assigned to consume in each
phase. A local brewery prepared the beers in similar containers to
maintain the blinding which was only revealed after the results
were analyzed. Randomization was performed by using online
software which generated a sequence of 44 numbers. Study
numbers were correlatively assigned to the participants and they
were assigned to a different intervention order based on the
computer generated sequence. Participants were asked to fill in a
daily questionnaire by recording all beers they consumed during
the study. If they skipped any prescribed beer, it was recorded
together with the reason on the beer was not consumed. The
questionnaire was reviewed by a researcher on each visit who
recorded consumption compliance. Participants were urged not to
consume other beers (both with alcohol and alcohol-free) during
the entire study.
Clinical, anthropometric and biochemical parameters along
with dietary and physical activity informationwere collected at the
following visits: randomization, end of the first phase, beginning of
the second phase and end of the second phase (Fig. 1). Intermediate
visits including clinical and anthropometric measurements and
dietary and physical activity assessments were performed in the
middle of each phase. These mid-phase visits intended to monitor
the study intervention and to reinforce lifestyle intervention.Please cite this article as: Mateo-Gallego R et al., Effect of an alcohol-fre
resistance in diabetic patients with overweight or obesity, Clinical Nutrit2.4. Diet and physical activity
Eligible participants were provided with counseling on cardio-
vascular healthy diet at pre-screening visits and at each study visit.
Dietary counseling included established recommendations for
subjects with T2DM and overweight or obesity. Advise included
higher consumption of fruits, vegetables, whole-grains, low-fat
dairy products and nuts and lower intake of red and processed
meats, sweetened soft-drinks, alcohol, sweets or snacks. Illustrative
sized portions were shown according to each participant's energy
requirements to try to achieve a restriction of calorie consumption.
All participants were providedwith general physical-activity advice
that was in accordance with their physical status. Physical activity
advice was quite heterogeneous due to the different fitness con-
ditions of subjects (i.e.: walk one hour a day or running 30 min
three times a week).
Diet and physical activity were monitored across the study to
control lifestyle factors that could interfere in the study findings.
Participants were asked to complete a 3-day weighed food record
before each visit. Dietary analysis was performed by an open source
online tool (© InsideMyFood.com) which is based on Spanish food-
composition tables [22]. The International Physical Activity Ques-
tionnaire (IPAQ), a brief validated exercise questionnaire, was
administered by direct interview from the researcher to the
participant [23].
2.5. Satiety questionnaire
Participants were instructed to complete a satiety questionnaire
60e90 min after drinking one of the alcohol-free beers along with
the eating food. We asked the volunteers to fill it in at 4 time-
points: once during the first 5 weeks of each phase and once dur-
ing the last 5 weeks. The questionnaire was based on visual
analogic scales (VAS) by including 8 questions regarding satiety and
fullness. It included 100 mm horizontal lines anchored with the
extremes of the subjective feeling of hunger to be quantified (i.e.:e beer enriched with isomaltulose and a resistant dextrin on insulin
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(100 mm). This scale is commonly used and validated to measure
appetite sensations and it is known to have good repeat reliability
between groups [24]. Subjects were asked to record the amounts
and times of eating all foods in the last 3 days. These amounts were
analyzed in relation to the consumption of the different beers and
to the proportions of calories, proteins, carbohydrates and fats
consumed. This data was analyzed by an open source software, as
previously explained.
2.6. Anthropometric and clinical parameters
Body weight was measured in subjects without shoes to the
nearest 0.1 kg with a calibrated scale (Seca 813, Seca Deutschland®,
Hamburg, Deutschland). Height was assessed to the nearest 0.1 cm
with a wall-mounted stadiometer (Seca 217, Seca Deutschland®,
Hamburg, Deutschland). BMI was calculated as weight in kilograms
divided by the square of height in meters. Waist circumference was
measured with anthropometric tape midway between the lowest
rib and the iliac crest. Body composition was assessed via bioelec-
trical impedance through the bipolar foot-to-foot technique (Tanita
TBF 410 GS, Omron Corporation®, Tokyo, Japan) [25]. All mea-
surements were taken in accordance with the recommended
guidelines: no food or drink 3 h prior to measurements, no
exhausting exercise 12 h prior to measurements, and no alcohol or
caffeine consumption 24 h prior to measurements. Blood pressure
was measured in triplicate with a validated semiautomatic oscill-
ometer (Omron M3, Omron Cop; Hoofdorp, the Netherlands).
2.7. Laboratory measurements
Blood samples were drawn by venipuncture after 12 h fasting.
The levels of total cholesterol, triglycerides, and HDL cholesterol,
uric acid, gamma-glutamyl transferasa (GGT), glutamic-pyruvic
transaminase (GPT) and aspartate transaminase (AST) were
measuredwith standard enzymatic methods. LDL cholesterol levels
were calculated with the Friedewald formula when serum tri-
glycerides were <400 mg/dL. Non-HDL cholesterol was calculated
as total cholesterol minus HDL cholesterol. Blood glucose concen-
tration was measured with the glucose-oxidase method. Insulin
levels were measured via radioimmunoassay. The homeostasis
model assessment of insulin resistance (HOMA-IR) was estimated
using fasting serum glucose (mg/dL) plasma insulin (mU/mL)/405.
HbA1c was determined via high-performance liquid chromatog-
raphy. C-reactive protein (CRP) was determined by nephelometry
using IMMAGE-Immunochemistry System (Beckman Coulter, USA).
2.8. Statistical analyses
HOMA-IR was established as the main outcome and its vari-
ability was estimated at 1.5 units. We expected a difference of
HOMA-IR of 0.70 among intervention groups after dietary inter-
vention. A total sample size of 41 subjects was obtained by
considering 80% power (Zb unilateral¼ 0.842) to detect a difference
between treatment groups and a confidence interval (1-a) of 90%
(Za unilateral ¼ 1.282). All subjects who completed the study were
included in the data analysis, independent of reported intervention
compliance according to intention-to-treat analysis. Continuous
variables are expressed as mean ± SD or median (25th percentile e
75th percentile) as applicable and categorical (nominal) variables
are reported as percentages of total sample. Differences between
independent variables were calculated by t-test or ManneWhitney
test, as appropriate, while categorical variables were compared
using the chi-squared test. Two-tailed t tests or the Wilcoxon rank-
sum test for paired samples as appropriate were used to comparePlease cite this article as: Mateo-Gallego R et al., Effect of an alcohol-fre
resistance in diabetic patients with overweight or obesity, Clinical Nutritchanges in outcome variables in response to each alcohol-free beer.
Differences between both alcohol-free beers across the study were
tested using linear mixed-effects models by including the 4 study
time-points. To examine whether there was any carryover effect
from intervention order and clinical and biochemical changes
across the study, we used multiple linear regressions by including
potential confounding factors (weight loss, energy intake and
physical activity after intervention, and intervention order) as in-
dependent variables and study outcomes as dependent variables.
All statistical analyses were performed with SPSS version 20.0
(SPSS Inc., Chicago, IL, USA) and R version 3.4.3 and significancewas
set at P < 0.05.
3. Results
3.1. Participants and study course
A total of 57 participants were examined for eligibility of which
43 met all inclusion/exclusion criteria. Just one participant (a man
beginning with alcohol-free beer with regular composition) drop-
ped out of the study because of personal reasons and he was not
included in the final analysis. As shown in Table 1, those parti-
cipants assigned to one of the two study intervention sequences did
not differ in terms of clinical or biochemical characteristics at
baseline (P > 0.05 for all parameters). Participants were mostly
middle-aged (55.8 ± 7.41 years) with a mean BMI of 31.9 ± 3.09 kg/
m2 and there were moremen thanwomen in both groups. Glucose,
insulin, HOMA-IR and HbA1c concentrations were 111 ± 18.6 mg/
dL, 9.90 ± 3.84 mg/dL, 2.70 ± 1.10 and 6.01 ± 0.59%, respectively, at
the beginning of the study. Eight participants were taking metfor-
min in stable doses during the whole study. The percentage of
volunteers taking metformin did not significantly differ between
those participants beginning with alcohol-free beer with modified
composition (N ¼ 6) and those starting by alcohol-free beer with
regular composition (N ¼ 2).
We observed a high compliance in beer consumption in both
intervention periods. Subjects reported 96.2% (95% CI: 94.8e97.5)
compliance during the period of consuming alcohol-free beer with
regular composition and 96.7% (95% CI: 95.5e97.8) compliance
during the period of consuming alcohol-free beer with modified
carbohydrates composition. High compliance was constant across
the study: 97.3% (95% CI: 96.1e98.4) at the intermediate visit and
95.2% (95% CI: 93.1e97.2) at the final visit in the regular alcohol-free
beers intervention period; and 97.1% (95% CI: 96.0e98.2) at the
intermediate visit and 96.3% (95% CI: 94.7e97.8) at the final visit in
modified composition alcohol-free beer period. The sequence of
study intervention did not significantly influence the compliance.
3.2. Weight loss and body composition
Subjects showed a significant weight loss in both
interventions:1.69± 3.21% (P¼ 0.004) in the period of consuming
the alcohol-beer with modified carbohydrates composition
and 1.77 ± 3.70% (P ¼ 0.007) in the period of consuming the
regular alcohol-free beer (Table 2). Weight loss did not significantly
differ between consumption periods of the two alcohol-free beers
according to intervention order (data not shown). A similar
significant decreasewas observed inwaist circumference after both
intervention periods while no significant change was observed in
body composition in any phase.
3.3. Glucose metabolism parameters
As indicated in Table 2 and in Fig. 2, blood glucose levels did not
significantly change in any phase. HbA1c slightly decreased aftere beer enriched with isomaltulose and a resistant dextrin on insulin
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Table 1
Clinical and biochemical characteristics at baseline according to dietary intervention sequence.a
Alcohol-free beer with regular composition/ Alcohol-free beer
with modified composition sequence
N ¼ 22
Alcohol-free beer with modified composition/ Alcohol-free beer
with regular composition sequence
N ¼ 21
Pb
Age, years 55.7 ± 8.68 55.9 ± 6.03 0.939
Gender, n (%) males 15 (68.2) 12 (57.1) 0.454
Weight, kg 90.6 ± 11.0 88.8 ± 11.8 0.618
Waist circumference, cm 113 [105e120] 110 [105e113] 0.265
Fat mass, kg 31.0 ± 7.12 30.6 ± 6.91 0.885
Fat free mass, kg 58.6 ± 10.8 57.5 ± 9.72 0.745
Visceral fat, levels 13.9 ± 3.42 13.6 ± 3.63 0.809
Systolic blood pressure,
mmHg
130 ± 16.9 129 ± 13.8 0.927
Diastolic blood pressure,
mmHg
85.0 ± 8.56 84.3 ± 9.21 0.794
Metformin, n (%) 2 (9.10) 6 (28.6) 0.132
Total cholesterol, mg/dL 208 ± 34.1 206 ± 30.9 0.815
HDL cholesterol, mg/dL 51.2 ± 7.90 52.7 ± 8.78 0.575
Triglycerides, mg/dL 111 ± 46.3 125 ± 51.1 0.211
LDL cholesterol, mg/dL 134 ± 27.6 133 ± 24.7 0.824
Apolipoprotein B, mg/dL 108 ± 31.6 114 ± 28.3 0.473
Glucose, mg/dL 112 ± 18.4 110 ± 19.1 0.706
Insulin, mg/dL 9.38 ± 3.36 10.4 ± 4.24 0.368
HOMA-IR 2.57 ± 0.91 2.84 ± 1.27 0.419
HbA1c, % 5.98 ± 0.67 6.05 ± 0.50 0.700
GGT, U/L 24.5 [18.5e35.0] 25.0 [21.5e39.5] 0.490
AST, U/L 22.0 [19.5e28.0] 24.5 [20.0e31.0] 0.955
GPT, U/L 23.3 ± 8.91 23.6 ± 10.0 0.905
Uric acid, mg/dL 6.32 ± 1.09 6.15 ± 1.80 0.707
CRP, mg/dL 0.17 [0.08e0.36] 0.27 [0.15e0.48] 0.198
a Values are expressed asmean ± SD ormedian (25th percentilee 75th percentile) as applicable. AST denotesaspartate transaminase; CRP; C-reactive protein; GGT, gamma-
glutamyl transferase; GPT, gamma-glutamyl transaminase; HbA1c, glycated hemoglobin; HOMA-IR, Homeostasis model assessment of insulin resistance.
b P refers to differences within each beer intervention period calculated by c2 test, t-test or ManneWhitney U test as applicable.
R. Mateo-Gallego et al. / Clinical Nutrition xxx (xxxx) xxx 5both phases 0.75 ± 5.16% after regular alcohol-free beer con-
sumption and1.11± 4.61% aftermodified alcohol-free beer intake,
with no differences within interventions (P ¼ 0.500 and P ¼ 0.177,
respectively). We did find significant differences between both
beers (P ¼ 0.001; Fig. 2) although differences disappeared after
adjusting by weight loss and other confounding factors. Insulin
concentrations significantly decreased by 11.1% (P ¼ 0.019) after
the intake of experimental alcohol-free beer while no significantTable 2
Percentage change in clinical and biochemical characteristics after each type of alcohol-
Alcohol-free beer with regular composition
D% change after intervention
N ¼ 43
Weight 1.77 ± 3.70
Waist circumference 2.87 ± 4.40
Fat mass 2.70 ± 9.95
Fat free mass 0.23 ± 3.62
Visceral fat 0 [e7.85e0]
Systolic blood pressure 2.93 ± 8.84
Diastolic blood pressure 3.70 ± 8.62
Total cholesterol 2.02 ± 10.8
HDL cholesterol 1.38 ± 9.72
Triglycerides 9.17 ± 33.8
LDL cholesterol 2.02 ± 14.7
Apolipoprotein B 4.54 [e9.60e15.8]
Glucose 0.21 ± 10.6
Insulin 1.64 [e20.518.2]
HOMA-IR 10.4 ± 59.6
HbA1c 0.75 ± 5.16
GGT 3.70 [e12.55.45]
AST 0.56 ± 20.1
GPT 0.02 ± 23.5
Uric acid 0.72 ± 10.3
CRP 11.1 [e32.250.0]
a Values are expressed asmean ± SD ormedian (25th percentilee 75th percentile) as ap
glutamyl transferase; GPT, gamma-glutamyl transaminase; HbA1c, glycated hemoglobin
b P refers to differences within each beer intervention period calculated by paired t-te
Please cite this article as: Mateo-Gallego R et al., Effect of an alcohol-fre
resistance in diabetic patients with overweight or obesity, Clinical Nutritchange was observed in the period consuming the regular beer
(P ¼ 0.812). We found statistically significant differences between
diets (P ¼ 0.043; Fig. 2) that remained significant after BMI change
and order intervention adjustment (P ¼ 0.001). However, the
significance was lost in the fully adjusted model (BMI change,
intervention order, gender, energy consumption, physical activity
and fat mass change), P ¼ 0.051. HOMA-IR significantly decreased
by1.92 ± 32.8% (P¼ 0.041) after consuming themodified alcohol-free beer.a
Alcohol-free beer with modified composition
Pb D% change after intervention
N ¼ 42
Pb
0.007 1.69 ± 3.21 0.004
0.006 1.55 ± 2.45 0.003
0.112 4.05 ± 9.94 0.167
0.833 0.28 ± 3.13 0.142
0.113 0 [e8.33e0] 0.243
0.020 1.46 ± 9.55 0.247
0.006 3.65 ± 9.17 0.046
0.309 6.44 ± 17.7 0.050
0.419 2.76 ± 8.98 0.047
0.268 0.41 ± 30.9 0.197
0.550 5.41 ± 19.7 0.029
0.881 1.06 [e9.33e13.2] 0.674
0.503 1.26 ± 12.2 0.751
0.812 11.1 [e21.34.64] 0.019
0.504 1.92 ± 32.8 0.041
0.500 1.11 ± 4.61 0.177
0.231 0.86 [e15.7e6.70] 0.566
0.326 6.01 ± 18.5 0.176
0.269 9.28 ± 34.2 0.434
0.377 0.77 ± 11.0 0.175
0.688 0 [e24.327.6] 0.519
plicable. AST denotes aspartate transaminase; CRP, C-reactive protein; GGT, gamma-
; HOMA-IR, Homeostasis model assessment of insulin resistance.
st or Wilcoxon test as applicable.
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significant change (10.4 ± 59.6%, P ¼ 0.504). There was statistical
significant differences in HOMA-IR change between both beers
(P < 0.001) that remained significant after adjusting by BMI change,
intervention order, gender, energy consumption, physical activity
and fat mass change (P ¼ 0.030).
3.4. Other cardiometabolic parameters
Systolic blood pressure significantly decreased just after the
regular alcohol-free beer period while diastolic blood pressure
significantly decreased after the consumption of both alcohol-free
beers. There were not significant differences between the two
alcohol-free beers in systolic (P ¼ 0.203) and diastolic (P ¼ 0.074)
blood pressure after adjusting for BMI change, intervention order,
gender, energy consumption, physical activity and fat mass change.
LDL and HDL cholesterol slightly and significantly increased during
the period of modified composition alcohol-free beer consumption
while no significant changewas observed during the regular alcohol-
free beer period. LDL cholesterol varied from 135 ± 25.2 mg/dL at
baseline to 139 ± 26.0 mg/dL at the end of intervention (P ¼ 0.029)
and HDL cholesterol increased from 52.5 ± 8.74 mg/dL to
54.0 ± 10.6 mg/dL (P ¼ 0.047). However, statistical differences dis-
appeared after adjusting by all confounding factors (BMI change,
intervention order, gender, energy consumption, physical activity
and fat mass change; P ¼ 0.104 and P ¼ 0.204 for LDL and HDL,
respectively). The rest of the biochemical parameters did not
significantly change after any intervention.
3.5. Dietary and physical activity parameters
Dietary characteristics reported by participants across the study
are included in Supplemental Table 2. Baseline dietary character-
istics did not significantly differ between both phases (P  0.05 forFig. 2. Glucose metabolism parameters change after each alcohol-free be
Please cite this article as: Mateo-Gallego R et al., Effect of an alcohol-fre
resistance in diabetic patients with overweight or obesity, Clinical Nutritall dietary parameters). Participants did not report a significant
change of energy intake in the period of consuming the regular
alcohol-free beer. However, a significant decrease in energy intake
at the intermediate visit in the period of consuming the experi-
mental alcohol-free beer was observed (P ¼ 0.013 across inter-
vention; P ¼ 0.024 comparing intermediate and final visits). The
percentage of fat intake also decreased at the intermediate visit in
the period in which participants were consuming modified
composition alcohol-free beer (P ¼ 0.023 across intervention,
P¼ 0.043 comparing intermediate and final visits). This changewas
mainly observed at the expense of saturated fat (P ¼ 0.007 across
interventions with experimental alcohol-free beer, P ¼ 0.022
comparing baseline and intermediate visits and P ¼ 0.003
comparing intermediate and final visits). Fiber and polyunsaturated
fatty acid intake heterogeneously changed during regular compo-
sition alcohol-free beer period (P ¼ 0.027 and P ¼ 0.017 across in-
terventions for fiber and polyunsaturated fatty acids, respectively).
Physical activity significantly differed at baseline between those
subjects beginning with regular and those starting with experi-
mental alcohol-free beer (1752 ± 1305 and 961 ± 732METS-h/week
respectively, P ¼ 0.025). However, baseline physical activity did not
significantly differ between both periods (P ¼ 0.140). During the
study physical activity changed by 49.7 ± 128% (P ¼ 0.569
comparing baseline and the final visit) in the period consuming
regular composition alcohol-free beer and it varied by 36.1 ± 88.6%
(P ¼ 0.030 comparing baseline and final visit) in the phase
consuming modified composition alcohol-free beer. For that
reason, we included physical activity change across the study in
full-adjustment models previously described.
3.6. Satiety assessment
As reported in Table 3, participants reported a mean fullness
score of 51.4± 5.26 (mean of the two satiety assessments during theer. 1Statistical significance tested using linear mixed-effects models.
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this score was 48.5 ± 8.55 after the intake of regular alcohol-free
beer (P ¼ 0.024 comparing both beers). These values were
adjusted by potential confounders: time since last alcohol-free beer
consumption and carbohydrates, fiber, proteins and fat intake in
the last meal. Subjects reported lower hunger scores (mean of
23.9 ± 7.10 between intermediate and final visits within interven-
tion) after experimental alcohol-free consumption comparing to
regular alcohol-free beer intake (mean of 26.9 ± 7.49 between in-
termediate and final visits within intervention), although no sig-
nificant differences were denoted (P ¼ 0.059). No differences were
detected in others questions regarding appetite and desire for
specific food types.
3.7. Adverse events
Subjects reported 31 non-severe adverse events across the
study: 13 occurred during the period subjects were consuming the
alcohol-free beer with modified composition and 18 during the
period under regular alcohol-free beer intervention. Seven adverse
events were related to mild gastrointestinal symptoms: 3 parti-
cipants reported abdominal discomfort (2 during the modified beer
consumption period and 1 during the regular beer consumption
beer), 2 subjects reported constipation, 1 subject reported
dyspepsia and 1 reported diarrhea. These last 5 adverse events
were observed during the regular alcohol-free beer consumption
period. All gastrointestinal adverse events were solved without
requiring medication or any other medical intervention.
4. Discussion
The main finding of this randomized, double-blind and cross-
over study was that the consumption, within main meals, of
66 cL per day of alcohol-free beer including the substitution of
regular carbohydrates by isomaltulose (16.5 g per day) and the
addition of a resistant maltodextrine (5.28 g per day) led to an
improvement in insulin resistance in subjects with T2DM and
overweight or obesity. This benefit was not denoted in while
consuming regular alcohol-free beer and it was observed regardless
of weight loss and other potential confounders like physical activ-
ity. Subjects reported higher satiety after consumption of modified
composition alcohol-free beer in comparison with the regular
alcohol-free beer consumption.
Different trials have revealed that isomaltulose decreases
glucose and insulin concentrations and leads to an increase in fat
oxidation in healthy, overweight and obese subjects [11,26e28].
Khalh€ofer et al. reported a 28% reduction in insulin secretion and 5%Table 3
Satiety assessment after each alcohol-free beer consumption.a
Questions Alcohol-free beer with regular co
Intermediate visit
N ¼ 32
Final visit
N ¼ 32
M
N
How hungry do you feel? 31.3 ± 7.74 24.1 ± 7.93 2
How satisfied do you feel? 50.4 ± 8.78 52.8 ± 10.4 5
How full do you feel? 45.3 ± 6.70 49.4 ± 10.7 4
How much do you think you can eat? 38.6 ± 11.2 42.6 ± 15.4 4
How strong is your desire to eat something sweet? 59.6 ± 13.4 60.9 ± 12.6 6
How strong is your desire to eat something salty? 55.1 ± 13.4 60.8 ± 13.1 5
How strong is your desire to eat something tasty? 56.0 ± 13.8 61.1 ± 11.6 5
How strong is your desire to eat something fatty? 78.1 ± 8.98 70.5 ± 11.9 7
a Values are expressed as mean ± SD. Questionnaire values have been adjusted by time
intake in the last meal.
b Mean of both visits refers to the mean between intermediate and final visit values i
c P refers to differences between the means in each alcohol-free beer period which is
Please cite this article as: Mateo-Gallego R et al., Effect of an alcohol-fre
resistance in diabetic patients with overweight or obesity, Clinical Nutritin blood glucose levels in healthy men consuming 37 g of iso-
maltulose during 7 days [29]. However, the effect of this carbohy-
drate in subjects with T2DM has been barely explored. Brunner
et al. did not observe significant changes in glucose metabolism
after intake of 50 g/d of isomaltulose during 12 weeks although
they did denote a significant decrease in triglycerides compared
with those participants consuming 50 g/d of sucrose [30]. Another
research study demonstrated that the ingestion of 1 g/kg-iso-
maltulose attenuated postprandial hyperglycemia by reducing oral
glucose appearance and inhibiting endogenous glucose production,
in comparison with the intake of rapidly absorbed sucrose in pa-
tients with T2DM [31]. Authors observed that isomaltulose
decreased the mean plasma concentrations of insulin, C-peptide,
glucagon, and glucose-dependent insulinotropic peptide by
10e23% in comparisonwith sucrose. Glucagon-like peptide-1 (GLP-
1) increased by 64% more and the cumulative amount of systemic
glucose appearance was 35% lower after isomaltulose than after
sucrose consumption. Similar metabolic effects have also been
described in healthy subjects [32].
To our knowledge, only two trials have determined the effect of
resistant dextrin, which is a prebiotic, on glucose metabolism and
both of them showed it to be beneficial. A clinical trial carried out in
60 healthy subjects showed a 18% decrease in plasma insulin after
intake of 17 g of resistant dextrin which was statistically signifi-
cantly higher than in controls [33]. A slightly higher glucose
metabolism improvement was observed in 55 women with T2DM
that were randomized to 10 g of resistant dextrin or placebo for 8
weeks. The researchers reported a significant 22.8% decrease in
insulin, 24.9% in HOMA-IR, 0.6% in glucose and 9.6% in HbA1c [13].
The benefits observed in glucose metabolism, weight loss and
inflammation have been attributed to two different mechanisms.
First, the supplementation with prebiotics has been demonstrated
to favor the differentiation of L-cells which promote secretion of
digestive hormones like GLP-1, peptide YY or gastric inhibitory
polypeptide, among others [34]. Second, increased levels of endo-
toxins have been reported in diabetic patients [35]. Increased
endotoxin levels like bacterial lipopolysacharides (metabolic
endotoxaemia) lead to disturbances in appetite regulation and the
expression of pro-inflammatory cytokines which are directly
related to decrease in insulin action [36e38]. It has been proposed
that resistant dextrin may contribute to themodulation of glycemic
status by reducing body weight and inflammatory biomarkers
through decreased metabolic endotoxaemia [13]. The modified
alcohol-free beer provided in our study involved lower doses of
isomaltulose and resistant dextrin than those used in prior
research. However, we observed significant 11.1% and 1.92%
decreases of insulin and HOMA-IR, respectively, which could be duemposition Alcohol-free beer with modified composition Pc
ean of both visitsb
¼ 32
Intermediate visit
N ¼ 32
Final visit
N ¼ 32
Mean of both visitsb
N ¼ 32
6.9 ± 7.49 28.1 ± 9.32 20.4 ± 5.85 23.9 ± 7.10 0.059
2.4 ± 9.71 51.7 ± 5.88 53.5 ± 8.32 52.7 ± 6.60 0.443
8.5 ± 8.55 52.6 ± 4.81 50.5 ± 7.02 51.4 ± 5.26 0.024
0.5 ± 13.2 37.4 ± 8.94 35.2 ± 9.12 36.4 ± 6.97 0.108
0.7 ± 10.3 54.2 ± 15.0 63.1 ± 12.4 58.6 ± 12.3 0.477
8.9 ± 12.6 56.6 ± 11.5 64.2 ± 6.89 60.5 ± 8.12 0.793
9.6 ± 11.6 55.5 ± 9.86 63.0 ± 9.22 59.8 ± 8.51 0.881
3.0 ± 10.6 69.3 ± 17.1 74.18 ± 6.97 71.6 ± 10.7 0.808
since last alcohol-free beer consumption and carbohydrates, fiber, proteins and fat
n that period.
calculated by paired t test.
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those previously reported in the studies above but that would be
consistent with a dose-dependent effect of these components. Also,
we advised the participants to take the alcohol-free beers with
meals which could have played an essential role in findings by
confirming the modulation of postprandial glycemia of both nu-
trients despite the low doses were used.
The participants reported higher satiety scores during the
period of drinking the alcohol-free beer with isomaltulose and
resistant dextrin than during the regular alcohol-free beer period.
However, we did not find a differential effect of the two beers in
weight loss. We observed a significant decrease in energy intake in
the first 5 weeks that subjects consumed alcohol-free beer with
modified composition but significance was lost at the end of that
study period. Previous trials have reported that resistant dextrin
increased satiety which was confirmed by key-appetite digestive
hormones like ghrelin [39,40]. Despite previous research involving
higher doses of both nutrients, their synergic effect could lead to a
higher satiety effect. We hypothesized that we did not denote an
enhanced-weight loss ability of modified alcohol-free beer because
of an acute effect on satiety or because higher doses of both nu-
trients are needed. Anyway, the possible satiety enhance ability of
the modified composition alcohol-free beer should be confirmed in
future studies by including the assessment of more sensitive
measurement of satiety and appetite biomarkers.
This study involved healthy lifestyle recommendations
including slight energy intake restriction, a cardiovascular healthy
dietary pattern (based on the Mediterranean diet) and an increase
of physical activity. Subjects showed a 1.77% mean weight loss
after the phase of consuming a regular composition alcohol-free
beer and 1.69% after the period of consuming the experimental
alcohol-free beer. Results demonstrated that inclusion of tasty and
light foods does not prevent body weight reduction and could even
be an incentive in weight loss management. Beyond calorie
counting, a recent report proposed that higheglycemic-load car-
bohydrates produce hormonal changes that promote calorie
deposition in adipose tissue, exacerbate hunger, and lower energy
expenditure [41]. Thus, it is crucial to go in depth into approaches
that ameliorate the negative influence of carbohydrates in
commonly consumed foods.
Our study has some limitations worth mentioning. The mid-
term length of intervention design could have influenced find-
ings, although previous interventional studies that have explored
the effect of isomaltulose and resistant dextrin have a shorter time
frame. The relatively small sample size could have limited the
significance of the effect of the intervention in some outcomes and
the extrapolation of findings. Although satiety has been explored
by VAS, which has been previously validated, an objective mea-
surement of appetite and satiety such as ghrelin or neuropeptide Y
assessment would be necessary to confirm our findings.
In conclusion, an alcohol-free beer including the substitution of
regular carbohydrates by isomaltulose (16.5 g per day) and the
addition of a resistant dextrin (5.28 g per day) within meals lead to
an improvement of insulin resistance (insulin concentration and
HOMA-IR) in subjects with T2DM and overweight or obesity. These
effects were observed within a lifestyle intervention and regardless
of weight loss, physical activity and other confounding factors. To
our knowledge, this is the first study employing relatively low
doses of isomaltulose and resistant dextrin that demonstrates that
a synergic effect of these nutrients could modulate postprandial
glycemia and improve glucose metabolism in subjects with T2DM.
Improvement in carbohydrate quality in the diet is a cornerstone
that merits further research based on its impact not only on glucose
metabolism but in overall metabolism. The inclusion of this
alcohol-free beer with modified carbohydrates composition couldPlease cite this article as: Mateo-Gallego R et al., Effect of an alcohol-fre
resistance in diabetic patients with overweight or obesity, Clinical Nutritbe part of a healthy diet by improving glycemia management but
also increasing the palatability of nutritional therapy.
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